Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation

Asaf Rotem(AstraZeneca (South Korea)), Kevin Struhl(Harvard University), Zhe Ji(Shanghai University of Engineering Science), Levi A. Garraway(Broad Institute), Andreas Janzer(Bayer (Germany)), Benjamin Izar(Columbia University Irving Medical Center), John G. Doench(Broad Institute)
Proceedings of the National Academy of Sciences
April 20, 2015
Cited by 138


Related Papers